imatinib

The data, however, suggest that Gleevec, generically known as imatinib, provides a treatment benefit.

Drug Shows Promise in Rare Lung Disease 2008

Among Thomson Reuters favorites for the Medicine prize are three scientists from the United States -- Brian Druker, Nicholas Lydon and Charles Sawyers -- who discovered and developed ground-breaking new drugs called imatinib and dasatinib for the treatment of chronic myeloid leukemia CML.

Yahoo! News: Business - Opinion 2011

Drug-chemo combo doubles survival in high-risk childhood leukaemia patients WASHINGTON - A new study has revealed that daily doses of a targeted drug called imatinib mesylate along with regular chemotherapy can almost double the survival rate of children with a high risk type of blood cancer called Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).

Gaea Times (by Simple Thoughts) Breaking News and incisive views 24/7 Ians 2010

Since 2002, a cancer drug known as imatinib (Gleevec) has been used against GIST tumors that have a particular mutation called KIT.

PhysOrg.com - latest science and technology news stories 2010

WASHINGTON - A new study has revealed that daily doses of a targeted drug called imatinib mesylate along with regular chemotherapy can almost double the survival rate of children with

Gaea Times (by Simple Thoughts) Breaking News and incisive views 24/7 2010

Drug-chemo combo doubles survival in high-risk childhood leukaemia patients WASHINGTON - A new study has revealed that daily doses of a targeted drug called imatinib mesylate along with regular chemotherapy can almost double the survival rate of children with a high risk type of blood cancer called Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).

Gaea Times (by Simple Thoughts) Breaking News and incisive views 24/7 Ians 2010

Scientists in Japan may have developed a way to accurately predict those patients who will resist treatment with imatinib, which is the standard of care for chronic myeloid

THE MEDICAL NEWS 2010

Individuals with chronic myeloid leukemia (CML) are first treated with a drug known as imatinib mesylate.

EurekAlert! - Breaking News 2009

Journal of Clinical Oncology show that adding continuous daily doses of a targeted drug called imatinib mesylate to regular chemotherapy more than doubled three-year survival rates for

WN.com - Articles related to Ponting wary of Men in Blue 2009

Oct 7 (ANI): A new study has revealed that daily doses of a targeted drug called imatinib mesylate along with regular chemotherapy can almost double the survival rate of An estimated 4,700 Canadians will learn they have leukemia in 2009, according to the Canadian Society.

WN.com - Articles related to Ponting wary of Men in Blue 2009